AU2002365925A1 - Rsv proteins, antibodies, compositions, methods and uses - Google Patents

Rsv proteins, antibodies, compositions, methods and uses

Info

Publication number: AU2002365925A1
Authority: AU; Australia
Prior art keywords: antibodies; compositions; methods; rsv proteins; rsv
Prior art date: 2001-11-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002365925A

Inventor

Bernard Scallon

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Centocor

Original Assignee

Centocor

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-02

Filing date

2002-10-26

Publication date

2003-09-02

2002-10-26 Application filed by Centocor filed Critical Centocor

2003-09-02 Publication of AU2002365925A1 publication Critical patent/AU2002365925A1/en

Status Abandoned legal-status Critical Current

Classifications

- C07K16/11—
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AU2002365925A 2001-11-02 2002-10-26 Rsv proteins, antibodies, compositions, methods and uses Abandoned AU2002365925A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US33608101P	2001-11-02	2001-11-02
US60/336,081		2001-11-02
US33783801P	2001-11-13	2001-11-13
US60/337,838		2001-11-13
PCT/US2002/034154 WO2003063767A2 (en)	2001-11-02	2002-10-26	Rsv proteins, antibodies, compositions, methods and uses

Publications (1)

Publication Number	Publication Date
AU2002365925A1 true AU2002365925A1 (en)	2003-09-02

Family

ID=27668884

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002365925A Abandoned AU2002365925A1 (en)	2001-11-02	2002-10-26	Rsv proteins, antibodies, compositions, methods and uses

Country Status (6)

Country	Link
EP (1)	EP1501870A4 (en)
JP (1)	JP2005522996A (en)
AU (1)	AU2002365925A1 (en)
CA (1)	CA2466025A1 (en)
MX (1)	MXPA04004224A (en)
WO (1)	WO2003063767A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2569919T3 (en)	1999-04-09	2016-05-13	Kyowa Hakko Kirin Co., Ltd.	Procedure to control the activity of an immunofunctional molecule
US6946292B2 (en)	2000-10-06	2005-09-20	Kyowa Hakko Kogyo Co., Ltd.	Cells producing antibody compositions with increased antibody dependent cytotoxic activity
JP4219932B2 (en)	2003-10-01	2009-02-04	協和発酵キリン株式会社	Antibody stabilization method and stabilized solution antibody preparation
JP5575377B2 (en)	2008-07-18	2014-08-20	シスメックス株式会社	RS virus detection kit and immunochromatography test device using anti-RS virus monoclonal antibody, and novel anti-RS virus monoclonal antibody

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2144043C (en) *	1992-09-16	2005-01-18	Dennis R. Burton	Human neutralizing monoclonal antibodies to respiratory syncytial virus
US5811524A (en) *	1995-06-07	1998-09-22	Idec Pharmaceuticals Corporation	Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
CA2270288A1 (en) *	1996-11-01	1998-05-14	Smithkline Beecham Corporation	Human monoclonal antibodies
WO2001064751A2 (en) *	2000-03-01	2001-09-07	Medimmune, Inc.	High potency recombinant antibodies and method for producing them

2002
- 2002-10-26 MX MXPA04004224A patent/MXPA04004224A/en not_active Application Discontinuation
- 2002-10-26 CA CA002466025A patent/CA2466025A1/en not_active Abandoned
- 2002-10-26 WO PCT/US2002/034154 patent/WO2003063767A2/en not_active Ceased
- 2002-10-26 EP EP02806688A patent/EP1501870A4/en not_active Withdrawn
- 2002-10-26 AU AU2002365925A patent/AU2002365925A1/en not_active Abandoned
- 2002-10-26 JP JP2003563463A patent/JP2005522996A/en active Pending

Also Published As

Publication number	Publication date
JP2005522996A (en)	2005-08-04
EP1501870A4 (en)	2006-05-03
WO2003063767A3 (en)	2004-12-02
WO2003063767A2 (en)	2003-08-07
CA2466025A1 (en)	2003-08-07
MXPA04004224A (en)	2005-03-31
EP1501870A2 (en)	2005-02-02

Similar Documents

Publication	Publication Date	Title
AU2002314825A1 (en)	2002-12-09	Anti-p40 immunoglobulin derived proteins, compositions, methods and uses
AU2002256895A1 (en)	2003-05-08	Anti-TRAIL-R antibodies
AU2002251913A1 (en)	2002-08-19	Hybrid antibodies and uses thereof
IL161968A0 (en)	2005-11-20	Anti-il-6 antibodies, compositions, methods and uses
AU2002365649A1 (en)	2003-06-17	Anti-dota antibody
AU2002314181A1 (en)	2003-03-03	Novel endothelially expressed dnas and proteins, and their use
AU2002359495A1 (en)	2003-06-17	Anti-tnf antibodies, compositions, methods and uses
AU2002336658A1 (en)	2003-05-12	Il-4 mutein proteins, antibodies, compositions, methods and uses
AUPR546801A0 (en)	2001-06-28	Recombinant antibodies
AU2003225976A1 (en)	2003-10-13	Anti-tnf antibodies, compositions, methods and uses
AU2002365269A1 (en)	2003-07-24	Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
WO2004003149A8 (en)	2005-03-31	Cngh0005 polypeptides, antibodies, compositions, methods and uses
AU2002331272A1 (en)	2003-03-03	Vegetarian protein foodstuff
AU2002305903A1 (en)	2002-12-09	Carbohydrate-associated proteins
AU2002345878A1 (en)	2003-01-08	Ilt3 and ilt4-related compositions and methods
AU2003237332A1 (en)	2003-12-19	Anti-relp fusion antibodies, compositions, methods and uses
AU2002306748A1 (en)	2002-10-03	Anti-gpe antibodies, their uses, and analytical methods for gpe
AU2002365894A1 (en)	2003-06-17	Antibodies to magmas and uses thereof
AU2002365925A1 (en)	2003-09-02	Rsv proteins, antibodies, compositions, methods and uses
AU2003220557A1 (en)	2003-10-13	Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses
AU2002250254A1 (en)	2002-09-24	Nucleic acids, proteins, and antibodies
AU2002316619A1 (en)	2003-01-29	Antimicrobial nucleic acid antibodies, and materials and methods for making and using same
AU2002334631A1 (en)	2003-04-01	Immune response associated proteins
AU2002357850A1 (en)	2003-06-30	Neurotransmission-associated proteins
AU2003218432A1 (en)	2003-10-13	Diabetes-related immunoglobulin derived proteins, compositions, methods and uses

Legal Events

Date	Code	Title	Description
2004-07-22	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase